PRESS RELEASE SUMMIT, N http://www.crmedicaltourism.com .J.— – Celgene Corporation today announced the election of Michael W. Bonney to its Table of Directors. Mr. Bonney served as Chief Executive Officer and a member of the Plank of Directors of Cubist Pharmaceuticals, Inc. From June 2003 until his retirement on December 31, 2014. In addition to his tenure as CEO of Cubist, Mr. Bonney's vast healthcare knowledge includes serving while President and Chief Operating Officer of Cubist from January 2002 to June 2003; holding several positions of increasing responsibility at Biogen, Inc., from 1995 – 2001; and serving in positions of raising responsibility in product sales, marketing and strategic setting up at Zeneca Pharmaceuticals over an eleven calendar year period.
Related StoriesUsing integrated molecular pathology to control incidental pancreatic cysts: an interview with Dr Ananya DasGenetic carrier screening: an interview with Don Hardison, CEO of Good Start GeneticsBrain health: how will you reduce cognitive decline? An interview with Heather Snyder, Ph.D.Spiegel teaches courses on cost-effectiveness analysis and health analytics in the UCLA School of Public Health, where he earned a get better at's level in Health Services Research. He has published a lot more than 130 manuscripts and three best-selling medical textbooks, and is a peer-reviewer and editorial board member or editor for numerous medical journals, like the American Journal of Gastroenterology. Dr. Spiegel is an ideal fit for the investigational function we're undertaking to improve quality and cost-effectiveness, stated Scott Weingarten, MD, MPH, senior vice president and chief clinical transformation officer.